GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Daxor DXR · USD

Health Care · US listing · 🇺🇸 United States

Compare

8.72

+3.20%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Net income

$9.2m

FY2016FY2025

Free cash flow

−$604,420

FY2016FY2025

Shareholders' equity

$45.9m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Research and development——$0$15$2$1$0———
Operating income$9.2m$621,423$329,742$5.3m$4.7m−$1.7m−$495,697−$1.1m−$1.1m$1.5m
Net income$9.2m$536,334$280,640$5.2m$4.7m−$1.7m−$495,697−$885,775−$1.2m$1.5m
Diluted earnings per share1.810.110.060.600.59-0.21-0.12-0.24-0.330.38

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$46.0m$36.6m$34.9m$30.3m$25.0m$16.6m$14.2m$17.6m$19.3m$20.6m
Cash and short-term investments————$710,700$617,800——$1.1m$2.2m
Total liabilities$122,595$840,296$858,758$1.3m$3.8m$877,689$1.4m$4.6m$5.6m$5.3m
Debt$112,000$729,966$755,659$1.2m$3.0m$170,689$1.3m$4.5m$4.3m$2.8m
Shareholders' equity$45.9m$35.8m$34.0m$29.0m$21.2m$15.7m$12.8m$13.1m$13.8m$15.3m
Shares outstanding5m5m5m9m8m8m4m4m4m4m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$604,420$25,692−$3.7m−$769,298−$2.8m−$2.4m$3.1m−$1.3m−$1.2m$1.6m
Capital spending—−$4−$1−$4−$3—————
Free cash flow−$604,420$25,688−$3.7m−$769,302−$2.8m−$2.4m$3.1m−$1.3m−$1.2m$1.6m
Dividends paid————————−$112,102−$113,989

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Mar 2024Dec 2023Sept 2023
Operating income−$3.3m$9.5m−$269,499$2.2m−$297,550−$148,775$3.1m−$210,793
Net income−$3.3m$9.5m−$369,701$2.2m−$1.6m−$815,409$3.3m$1.7m
Diluted earnings per share-0.661.89-0.070.44-0.33-0.170.720.36
Cash from operations−$2.0m———−$1.0m—−$3.0m—
Total assets$51.9m$46.0m$35.9m$36.6m$34.4m$34.4m$34.9m$34.9m
Cash and short-term investments$5.8m———————
Shareholders' equity$51.8m$45.9m$35.6m$35.8m$32.7m$32.7m$34.0m$34.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-57.0%——
Operating income20.5%——
Net income21.0%——

Average margins

Over each period

1 year3 years5 years10 years
Operating margin372.3%35.3%38.1%22.7%
Net margin368.4%34.8%37.7%19.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings8.170.8158.415.219.2-59.1-79.4-34.7-13.821.5
Price to sales148.217.81.312.515.7-101.2-342.2-33.5-16.917.1

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return51%-3%-13%-12%-13%32%35%47%-43%12%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 5 Jan 2018.

FY2017FY2016FY2015FY2014FY2013FY2012FY2011FY2010
Paid in the year0.030.030.040.030.050.200.251.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.